| TIME | ARTICLE |
JOURNAL |
IF | PUBMED ID | PRODUCT |
|---|---|---|---|---|---|
| 2021 | LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing | Oncogene. | 7.971 | 34140643 | |
| 2020 | DOCK6 promotes chemo- and radioresistance of gastric cancer bymodulating WNT/β-catenin signaling and cancer stem cell traits | Oncogene. | 7.971 | 32753649 | |
| 2022 | Organ defects of the Usp7 mutant mouse strain indicate the essential role of K63-polyubiquitinated Usp7 in organ formation | Biomedical Journal | 7.892 | 35183794 | |
| 2022 | LPAL2 suppresses tumor growth and metastasis of hepatocellular carcinoma by modulating MMP9 expression | Cells | 7.666 | 36010685 | |
| 2022 | USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1 | Cells | 7.607 | 36291159 | |
| 2024 | Isoliquiritigenin inhibits apoptosis and ameliorates oxidative stress in rheumatoid arthritis chondrocytes through the Nrf2/ HO-1-mediated pathway | Biomedicine & Pharmacotherapy | 7.5 | 38091640 | |
| 2023 | Boosting mitochondrial function and metabolism in aging female germ cells with dual ROCK/ROS inhibition. | Biomed Pharmacother | 7.5 | 37196543 | |
| 2023 | Boosting mitochondrial function and metabolism in aging female germ cells with dual ROCK/ROS inhibition | Biomedicine & Pharmacotherapy | 7.419 | 37196543 | |
| 2022 | The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs | Biomedicine & Pharmacotherapy | 7.419 | 36068781 |
